Cargando…
Current State-of-the-art Cutting-edge Technologies for Nanonutraceuticals in Cancer
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642583/ https://www.ncbi.nlm.nih.gov/pubmed/37969615 http://dx.doi.org/10.4103/jrpp.jrpp_6_23 |
| _version_ | 1785146994685116416 |
|---|---|
| author | Kutikuppala, L. V. Simhachalam Kalyani, Ponnaganti Sai Venkata Boppana, Sri Harsha Mohapatra, Ranjan K. |
| author_facet | Kutikuppala, L. V. Simhachalam Kalyani, Ponnaganti Sai Venkata Boppana, Sri Harsha Mohapatra, Ranjan K. |
| author_sort | Kutikuppala, L. V. Simhachalam |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10642583 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106425832023-11-15 Current State-of-the-art Cutting-edge Technologies for Nanonutraceuticals in Cancer Kutikuppala, L. V. Simhachalam Kalyani, Ponnaganti Sai Venkata Boppana, Sri Harsha Mohapatra, Ranjan K. J Res Pharm Pract Letter to the Editor Wolters Kluwer - Medknow 2023-08-29 /pmc/articles/PMC10642583/ /pubmed/37969615 http://dx.doi.org/10.4103/jrpp.jrpp_6_23 Text en Copyright: © 2023 Journal of Research in Pharmacy Practice https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Letter to the Editor Kutikuppala, L. V. Simhachalam Kalyani, Ponnaganti Sai Venkata Boppana, Sri Harsha Mohapatra, Ranjan K. Current State-of-the-art Cutting-edge Technologies for Nanonutraceuticals in Cancer |
| title | Current State-of-the-art Cutting-edge Technologies for Nanonutraceuticals in Cancer |
| title_full | Current State-of-the-art Cutting-edge Technologies for Nanonutraceuticals in Cancer |
| title_fullStr | Current State-of-the-art Cutting-edge Technologies for Nanonutraceuticals in Cancer |
| title_full_unstemmed | Current State-of-the-art Cutting-edge Technologies for Nanonutraceuticals in Cancer |
| title_short | Current State-of-the-art Cutting-edge Technologies for Nanonutraceuticals in Cancer |
| title_sort | current state-of-the-art cutting-edge technologies for nanonutraceuticals in cancer |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642583/ https://www.ncbi.nlm.nih.gov/pubmed/37969615 http://dx.doi.org/10.4103/jrpp.jrpp_6_23 |
| work_keys_str_mv | AT kutikuppalalvsimhachalam currentstateoftheartcuttingedgetechnologiesfornanonutraceuticalsincancer AT kalyaniponnagantisaivenkata currentstateoftheartcuttingedgetechnologiesfornanonutraceuticalsincancer AT boppanasriharsha currentstateoftheartcuttingedgetechnologiesfornanonutraceuticalsincancer AT mohapatraranjank currentstateoftheartcuttingedgetechnologiesfornanonutraceuticalsincancer |